Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0503 Transporter Info | ||||
Gene Name | SLCO4C1 | ||||
Transporter Name | Organic anion transporting polypeptide 4C1 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Pancretic ductal adenocarcinoma |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLCO4C1 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
5'UTR (cg03721454) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:6.36E-03; Z-score:4.25E-01 | ||
Methylation in Case |
7.18E-01 (Median) | Methylation in Control | 6.91E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLCO4C1 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
TSS1500 (cg14482308) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.54E+00 | Statistic Test | p-value:2.66E-14; Z-score:2.24E+00 | ||
Methylation in Case |
4.32E-01 (Median) | Methylation in Control | 2.80E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLCO4C1 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
TSS1500 (cg26360695) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.19E+00 | Statistic Test | p-value:3.39E-03; Z-score:-8.12E-01 | ||
Methylation in Case |
1.16E-01 (Median) | Methylation in Control | 1.39E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLCO4C1 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
TSS1500 (cg23375719) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.19E+00 | Statistic Test | p-value:6.26E-03; Z-score:-4.47E-01 | ||
Methylation in Case |
1.17E-01 (Median) | Methylation in Control | 1.39E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLCO4C1 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg17221813) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.08E+00 | Statistic Test | p-value:3.56E-04; Z-score:8.90E-01 | ||
Methylation in Case |
7.88E-01 (Median) | Methylation in Control | 7.29E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLCO4C1 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg10117207) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.18E+00 | Statistic Test | p-value:1.17E-03; Z-score:1.09E+00 | ||
Methylation in Case |
8.56E-01 (Median) | Methylation in Control | 7.28E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLCO4C1 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg04070804) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:4.54E-03; Z-score:9.05E-01 | ||
Methylation in Case |
8.74E-01 (Median) | Methylation in Control | 8.44E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLCO4C1 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg18312989) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.07E+00 | Statistic Test | p-value:1.27E-02; Z-score:-6.01E-01 | ||
Methylation in Case |
5.07E-01 (Median) | Methylation in Control | 5.45E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLCO4C1 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
3'UTR (cg14022794) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.10E+00 | Statistic Test | p-value:9.93E-04; Z-score:-9.85E-01 | ||
Methylation in Case |
3.45E-01 (Median) | Methylation in Control | 3.80E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLCO4C1 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg12864568) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-2.36E+00 | Statistic Test | p-value:2.76E-06; Z-score:-5.46E+00 | ||
Methylation in Case |
1.13E-01 (Median) | Methylation in Control | 2.67E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLCO4C1 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg24036612) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:2.72E-03; Z-score:-4.69E+00 | ||
Methylation in Case |
8.20E-01 (Median) | Methylation in Control | 8.65E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLCO4C1 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg19774478) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.86E+00 | Statistic Test | p-value:1.24E-02; Z-score:-2.34E+00 | ||
Methylation in Case |
7.08E-02 (Median) | Methylation in Control | 1.32E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLCO4C1 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg19774478) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:2.83E-03; Z-score:-2.13E-02 | ||
Methylation in Case |
7.56E-02 (Median) | Methylation in Control | 7.62E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLCO4C1 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg24036612) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:3.08E-02; Z-score:-7.04E-01 | ||
Methylation in Case |
8.44E-01 (Median) | Methylation in Control | 8.69E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLCO4C1 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg19788741) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.09E+00 | Statistic Test | p-value:5.54E-03; Z-score:-1.40E-01 | ||
Methylation in Case |
3.24E-02 (Median) | Methylation in Control | 3.53E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLCO4C1 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg11267955) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.12E+00 | Statistic Test | p-value:6.44E-03; Z-score:-4.26E-01 | ||
Methylation in Case |
5.47E-02 (Median) | Methylation in Control | 6.15E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLCO4C1 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg04633600) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.11E+00 | Statistic Test | p-value:1.58E-02; Z-score:3.03E-01 | ||
Methylation in Case |
4.91E-02 (Median) | Methylation in Control | 4.41E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLCO4C1 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg04621020) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.09E+00 | Statistic Test | p-value:2.01E-02; Z-score:-4.02E-01 | ||
Methylation in Case |
5.96E-02 (Median) | Methylation in Control | 6.52E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLCO4C1 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg06480736) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:2.01E-02; Z-score:-2.38E-01 | ||
Methylation in Case |
6.40E-02 (Median) | Methylation in Control | 6.79E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLCO4C1 in breast cancer | [ 3 ] | |||
Location |
Body (cg23318786) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.10E+00 | Statistic Test | p-value:1.39E-02; Z-score:2.18E-01 | ||
Methylation in Case |
2.73E-02 (Median) | Methylation in Control | 2.49E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLCO4C1 in breast cancer | [ 3 ] | |||
Location |
3'UTR (cg00630480) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:7.63E-07; Z-score:9.00E-01 | ||
Methylation in Case |
6.03E-01 (Median) | Methylation in Control | 5.52E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLCO4C1 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg12864568) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.66E+00 | Statistic Test | p-value:3.80E-02; Z-score:-1.81E+00 | ||
Methylation in Case |
1.15E-01 (Median) | Methylation in Control | 1.91E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLCO4C1 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS200 (cg22149516) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.46E+00 | Statistic Test | p-value:1.17E-02; Z-score:-1.17E+00 | ||
Methylation in Case |
6.30E-02 (Median) | Methylation in Control | 9.18E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLCO4C1 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
Body (cg23318786) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:1.17E-03; Z-score:3.23E-01 | ||
Methylation in Case |
1.82E-02 (Median) | Methylation in Control | 1.74E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLCO4C1 in colon adenocarcinoma | [ 5 ] | |||
Location |
TSS1500 (cg03586474) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.77E+00 | Statistic Test | p-value:1.80E-03; Z-score:3.56E+00 | ||
Methylation in Case |
2.33E-01 (Median) | Methylation in Control | 1.32E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLCO4C1 in colon adenocarcinoma | [ 5 ] | |||
Location |
Body (cg03366891) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.10E+00 | Statistic Test | p-value:2.16E-04; Z-score:-3.03E+00 | ||
Methylation in Case |
7.22E-01 (Median) | Methylation in Control | 7.96E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
13 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLCO4C1 in colorectal cancer | [ 6 ] | |||
Location |
TSS1500 (cg19774478) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.33E+00 | Statistic Test | p-value:3.68E-05; Z-score:1.02E+00 | ||
Methylation in Case |
2.53E-01 (Median) | Methylation in Control | 1.91E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLCO4C1 in colorectal cancer | [ 6 ] | |||
Location |
TSS1500 (cg12864568) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.56E+00 | Statistic Test | p-value:1.26E-04; Z-score:1.62E+00 | ||
Methylation in Case |
4.54E-01 (Median) | Methylation in Control | 2.91E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLCO4C1 in colorectal cancer | [ 6 ] | |||
Location |
TSS200 (cg04621020) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:5.44E+00 | Statistic Test | p-value:4.80E-13; Z-score:6.66E+00 | ||
Methylation in Case |
5.50E-01 (Median) | Methylation in Control | 1.01E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLCO4C1 in colorectal cancer | [ 6 ] | |||
Location |
TSS200 (cg06480736) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:6.46E+00 | Statistic Test | p-value:2.11E-12; Z-score:7.33E+00 | ||
Methylation in Case |
3.71E-01 (Median) | Methylation in Control | 5.74E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLCO4C1 in colorectal cancer | [ 6 ] | |||
Location |
TSS200 (cg11267955) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:8.40E+00 | Statistic Test | p-value:3.88E-12; Z-score:7.65E+00 | ||
Methylation in Case |
4.00E-01 (Median) | Methylation in Control | 4.76E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLCO4C1 in colorectal cancer | [ 6 ] | |||
Location |
TSS200 (cg19788741) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.18E+01 | Statistic Test | p-value:4.49E-12; Z-score:6.05E+00 | ||
Methylation in Case |
4.42E-01 (Median) | Methylation in Control | 3.73E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLCO4C1 in colorectal cancer | [ 6 ] | |||
Location |
TSS200 (cg22149516) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:3.42E+00 | Statistic Test | p-value:4.74E-12; Z-score:4.35E+00 | ||
Methylation in Case |
5.86E-01 (Median) | Methylation in Control | 1.71E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLCO4C1 in colorectal cancer | [ 6 ] | |||
Location |
TSS200 (cg11009817) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:3.59E+00 | Statistic Test | p-value:1.05E-11; Z-score:5.09E+00 | ||
Methylation in Case |
4.04E-01 (Median) | Methylation in Control | 1.12E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLCO4C1 in colorectal cancer | [ 6 ] | |||
Location |
TSS200 (cg04633600) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:4.17E+00 | Statistic Test | p-value:2.90E-10; Z-score:6.04E+00 | ||
Methylation in Case |
2.08E-01 (Median) | Methylation in Control | 5.00E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLCO4C1 in colorectal cancer | [ 6 ] | |||
Location |
1stExon (cg00056676) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.44E+00 | Statistic Test | p-value:2.86E-08; Z-score:2.44E+00 | ||
Methylation in Case |
1.69E-01 (Median) | Methylation in Control | 1.17E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLCO4C1 in colorectal cancer | [ 6 ] | |||
Location |
Body (cg23318786) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.37E+00 | Statistic Test | p-value:1.46E-08; Z-score:5.96E+00 | ||
Methylation in Case |
4.58E-02 (Median) | Methylation in Control | 1.93E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLCO4C1 in colorectal cancer | [ 6 ] | |||
Location |
3'UTR (cg00630480) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:8.49E-05; Z-score:-1.23E+00 | ||
Methylation in Case |
7.04E-01 (Median) | Methylation in Control | 7.47E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLCO4C1 in hepatocellular carcinoma | [ 7 ] | |||
Location |
TSS1500 (cg19774478) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.33E+00 | Statistic Test | p-value:6.88E-06; Z-score:1.35E+00 | ||
Methylation in Case |
1.32E-01 (Median) | Methylation in Control | 9.96E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLCO4C1 in hepatocellular carcinoma | [ 7 ] | |||
Location |
TSS1500 (cg24036612) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:4.53E-05; Z-score:-6.01E-01 | ||
Methylation in Case |
7.70E-01 (Median) | Methylation in Control | 8.03E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLCO4C1 in hepatocellular carcinoma | [ 7 ] | |||
Location |
TSS200 (cg11267955) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:3.01E+00 | Statistic Test | p-value:3.07E-09; Z-score:4.29E+00 | ||
Methylation in Case |
1.58E-01 (Median) | Methylation in Control | 5.25E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLCO4C1 in hepatocellular carcinoma | [ 7 ] | |||
Location |
TSS200 (cg04621020) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.43E+00 | Statistic Test | p-value:5.14E-09; Z-score:5.54E+00 | ||
Methylation in Case |
1.60E-01 (Median) | Methylation in Control | 6.57E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLCO4C1 in hepatocellular carcinoma | [ 7 ] | |||
Location |
TSS200 (cg06480736) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.91E+00 | Statistic Test | p-value:6.97E-09; Z-score:2.44E+00 | ||
Methylation in Case |
1.33E-01 (Median) | Methylation in Control | 6.97E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLCO4C1 in hepatocellular carcinoma | [ 7 ] | |||
Location |
TSS200 (cg11009817) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.64E+00 | Statistic Test | p-value:2.20E-07; Z-score:3.38E+00 | ||
Methylation in Case |
1.03E-01 (Median) | Methylation in Control | 6.31E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLCO4C1 in hepatocellular carcinoma | [ 7 ] | |||
Location |
TSS200 (cg04633600) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.26E+00 | Statistic Test | p-value:2.35E-06; Z-score:6.92E-01 | ||
Methylation in Case |
6.60E-02 (Median) | Methylation in Control | 5.24E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLCO4C1 in hepatocellular carcinoma | [ 7 ] | |||
Location |
1stExon (cg00056676) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.03E+00 | Statistic Test | p-value:2.74E-02; Z-score:1.70E-01 | ||
Methylation in Case |
8.40E-02 (Median) | Methylation in Control | 8.17E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLCO4C1 in hepatocellular carcinoma | [ 7 ] | |||
Location |
Body (cg09647867) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.36E+00 | Statistic Test | p-value:3.68E-15; Z-score:-4.63E+00 | ||
Methylation in Case |
4.92E-01 (Median) | Methylation in Control | 6.69E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLCO4C1 in HIV infection | [ 8 ] | |||
Location |
TSS1500 (cg19774478) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.18E+00 | Statistic Test | p-value:4.15E-03; Z-score:6.51E-01 | ||
Methylation in Case |
5.83E-02 (Median) | Methylation in Control | 4.95E-02 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLCO4C1 in HIV infection | [ 8 ] | |||
Location |
TSS1500 (cg12864568) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.32E+00 | Statistic Test | p-value:1.88E-02; Z-score:1.07E+00 | ||
Methylation in Case |
8.71E-02 (Median) | Methylation in Control | 6.59E-02 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLCO4C1 in HIV infection | [ 8 ] | |||
Location |
TSS200 (cg19788741) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.32E+00 | Statistic Test | p-value:4.15E-03; Z-score:1.06E+00 | ||
Methylation in Case |
2.92E-02 (Median) | Methylation in Control | 2.20E-02 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLCO4C1 in HIV infection | [ 8 ] | |||
Location |
TSS200 (cg11009817) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:2.66E-02; Z-score:3.03E-01 | ||
Methylation in Case |
4.28E-02 (Median) | Methylation in Control | 4.00E-02 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLCO4C1 in HIV infection | [ 8 ] | |||
Location |
TSS200 (cg06480736) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.12E+00 | Statistic Test | p-value:4.39E-02; Z-score:4.27E-01 | ||
Methylation in Case |
5.19E-02 (Median) | Methylation in Control | 4.64E-02 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLCO4C1 in HIV infection | [ 8 ] | |||
Location |
TSS200 (cg04633600) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.12E+00 | Statistic Test | p-value:4.62E-02; Z-score:5.51E-01 | ||
Methylation in Case |
8.50E-02 (Median) | Methylation in Control | 7.62E-02 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLCO4C1 in HIV infection | [ 8 ] | |||
Location |
Body (cg23318786) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.40E+00 | Statistic Test | p-value:2.49E-03; Z-score:6.90E-01 | ||
Methylation in Case |
1.99E-02 (Median) | Methylation in Control | 1.42E-02 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLCO4C1 in papillary thyroid cancer | [ 9 ] | |||
Location |
TSS1500 (cg24036612) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:2.27E-04; Z-score:-7.93E-01 | ||
Methylation in Case |
8.59E-01 (Median) | Methylation in Control | 8.76E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLCO4C1 in papillary thyroid cancer | [ 9 ] | |||
Location |
TSS200 (cg11009817) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.26E+00 | Statistic Test | p-value:4.73E-02; Z-score:-1.03E+00 | ||
Methylation in Case |
6.82E-02 (Median) | Methylation in Control | 8.58E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLCO4C1 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg23318786) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:8.47E-03; Z-score:2.63E-01 | ||
Methylation in Case |
5.49E-02 (Median) | Methylation in Control | 5.30E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLCO4C1 in prostate cancer | [ 10 ] | |||
Location |
TSS1500 (cg27365825) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:3.05E+00 | Statistic Test | p-value:3.12E-04; Z-score:1.13E+01 | ||
Methylation in Case |
6.29E-01 (Median) | Methylation in Control | 2.06E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Moderate hypermethylation of SLCO4C1 in prostate cancer than that in healthy individual | ||||
Studied Phenotype |
Prostate cancer [ICD-11:2C82] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:3.84E-29; Fold-change:0.221026205; Z-score:10.80695502 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Lung adenocarcinoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLCO4C1 in lung adenocarcinoma | [ 11 ] | |||
Location |
TSS200 (cg11009817) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.28E+00 | Statistic Test | p-value:1.02E-02; Z-score:-1.76E+00 | ||
Methylation in Case |
9.22E-02 (Median) | Methylation in Control | 1.18E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLCO4C1 in systemic lupus erythematosus | [ 12 ] | |||
Location |
TSS200 (cg19788741) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:3.82E-03; Z-score:1.68E-01 | ||
Methylation in Case |
2.67E-02 (Median) | Methylation in Control | 2.54E-02 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLCO4C1 in systemic lupus erythematosus | [ 12 ] | |||
Location |
TSS200 (cg06480736) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:5.84E-03; Z-score:1.68E-01 | ||
Methylation in Case |
5.73E-02 (Median) | Methylation in Control | 5.52E-02 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLCO4C1 in systemic lupus erythematosus | [ 12 ] | |||
Location |
3'UTR (cg00630480) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.00E+00 | Statistic Test | p-value:2.28E-02; Z-score:-5.57E-02 | ||
Methylation in Case |
8.32E-01 (Median) | Methylation in Control | 8.35E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Atypical teratoid rhabdoid tumor |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLCO4C1 in atypical teratoid rhabdoid tumor | [ 13 ] | |||
Location |
1stExon (cg00056676) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-2.70E+00 | Statistic Test | p-value:3.86E-42; Z-score:-6.50E+00 | ||
Methylation in Case |
2.99E-01 (Median) | Methylation in Control | 8.07E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLCO4C1 in atypical teratoid rhabdoid tumor | [ 13 ] | |||
Location |
3'UTR (cg00630480) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.14E+00 | Statistic Test | p-value:1.15E-15; Z-score:-2.99E+00 | ||
Methylation in Case |
7.78E-01 (Median) | Methylation in Control | 8.89E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLCO4C1 in panic disorder | [ 14 ] | |||
Location |
Body (cg23318786) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-9.92E-01 | Statistic Test | p-value:2.58E-02; Z-score:-2.31E-01 | ||
Methylation in Case |
-5.48E+00 (Median) | Methylation in Control | -5.43E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLCO4C1 in panic disorder | [ 14 ] | |||
Location |
3'UTR (cg00630480) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.68E+00 | Statistic Test | p-value:2.54E-06; Z-score:-8.11E-01 | ||
Methylation in Case |
5.29E-01 (Median) | Methylation in Control | 8.88E-01 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Glioblastoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypermethylation of SLCO4C1 in glioblastoma than that in healthy individual | ||||
Studied Phenotype |
Glioblastoma [ICD-11:2A00.00] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:2.03E-09; Fold-change:0.481928989; Z-score:2.094793725 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Lymphoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypermethylation of SLCO4C1 in lymphoma than that in healthy individual | ||||
Studied Phenotype |
Lymphoma [ICD-11:2B30] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:4.10E-12; Fold-change:0.469252292; Z-score:2.714278546 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Malignant astrocytoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypermethylation of SLCO4C1 in malignant astrocytoma than that in healthy individual | ||||
Studied Phenotype |
Malignant astrocytoma [ICD-11:2A00.12] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:1.53E-64; Fold-change:0.448187519; Z-score:3.221077222 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Multilayered rosettes embryonal tumour |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypermethylation of SLCO4C1 in multilayered rosettes embryonal tumour than that in healthy individual | ||||
Studied Phenotype |
Multilayered rosettes embryonal tumour [ICD-11:2A00.1] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:4.00E-31; Fold-change:0.725989969; Z-score:4.631156229 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Oligodendroglial tumour |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypermethylation of SLCO4C1 in oligodendroglial tumour than that in healthy individual | ||||
Studied Phenotype |
Oligodendroglial tumour [ICD-11:2A00.Y1] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:2.04E-08; Fold-change:0.333051983; Z-score:6.95185281 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Oligodendroglioma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypermethylation of SLCO4C1 in oligodendroglioma than that in healthy individual | ||||
Studied Phenotype |
Oligodendroglioma [ICD-11:2A00.0Y] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:6.00E-25; Fold-change:0.402987977; Z-score:2.33098834 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Prostate cancer metastasis |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypermethylation of SLCO4C1 in prostate cancer metastasis than that in healthy individual | ||||
Studied Phenotype |
Prostate cancer metastasis [ICD-11:2.00E+06] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:3.28E-06; Fold-change:0.577116201; Z-score:22.24530136 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
microRNA |
|||||
Unclear Phenotype |
25 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
miR-518f directly targets SLCO4C1 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Microarray | ||
Related Molecular Changes | Down regulation ofSLCO4C1 | Experiment Method | qRT-PCR | ||
miRNA Stemloop ID |
miR-518f | miRNA Mature ID | miR-518f-3p | ||
miRNA Sequence |
GAAAGCGCUUCUCUUUAGAGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Additional Notes |
SLCO4C1 the predicted target of miR 518f-3p was determined in cell lysates of PBMCs infected with HIV-1 or HIV-2. | ||||
Epigenetic Phenomenon2 |
miR-1185 directly targets SLCO4C1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1185 | miRNA Mature ID | miR-1185-5p | ||
miRNA Sequence |
AGAGGAUACCCUUUGUAUGUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon3 |
miR-1224 directly targets SLCO4C1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1224 | miRNA Mature ID | miR-1224-5p | ||
miRNA Sequence |
GUGAGGACUCGGGAGGUGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon4 |
miR-124 directly targets SLCO4C1 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-124 | miRNA Mature ID | miR-124-5p | ||
miRNA Sequence |
CGUGUUCACAGCGGACCUUGAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon5 |
miR-1264 directly targets SLCO4C1 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-1264 | miRNA Mature ID | miR-1264 | ||
miRNA Sequence |
CAAGUCUUAUUUGAGCACCUGUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon6 |
miR-148b directly targets SLCO4C1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Microarray | ||
miRNA Stemloop ID |
miR-148b | miRNA Mature ID | miR-148b-3p | ||
miRNA Sequence |
UCAGUGCAUCACAGAACUUUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human cervical cancer cell line (Hela) | ||||
Epigenetic Phenomenon7 |
miR-2115 directly targets SLCO4C1 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-2115 | miRNA Mature ID | miR-2115-5p | ||
miRNA Sequence |
AGCUUCCAUGACUCCUGAUGGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon8 |
miR-335 directly targets SLCO4C1 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Microarray | ||
miRNA Stemloop ID |
miR-335 | miRNA Mature ID | miR-335-5p | ||
miRNA Sequence |
UCAAGAGCAAUAACGAAAAAUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon9 |
miR-3605 directly targets SLCO4C1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-3605 | miRNA Mature ID | miR-3605-5p | ||
miRNA Sequence |
UGAGGAUGGAUAGCAAGGAAGCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon10 |
miR-3679 directly targets SLCO4C1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-3679 | miRNA Mature ID | miR-3679-5p | ||
miRNA Sequence |
UGAGGAUAUGGCAGGGAAGGGGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon11 |
miR-3692 directly targets SLCO4C1 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3692 | miRNA Mature ID | miR-3692-3p | ||
miRNA Sequence |
GUUCCACACUGACACUGCAGAAGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon12 |
miR-3915 directly targets SLCO4C1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-3915 | miRNA Mature ID | miR-3915 | ||
miRNA Sequence |
UUGAGGAAAAGAUGGUCUUAUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon13 |
miR-3938 directly targets SLCO4C1 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3938 | miRNA Mature ID | miR-3938 | ||
miRNA Sequence |
AAUUCCCUUGUAGAUAACCCGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon14 |
miR-4455 directly targets SLCO4C1 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4455 | miRNA Mature ID | miR-4455 | ||
miRNA Sequence |
AGGGUGUGUGUGUUUUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon15 |
miR-4689 directly targets SLCO4C1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4689 | miRNA Mature ID | miR-4689 | ||
miRNA Sequence |
UUGAGGAGACAUGGUGGGGGCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon16 |
miR-516a directly targets SLCO4C1 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-516a | miRNA Mature ID | miR-516a-3p | ||
miRNA Sequence |
UGCUUCCUUUCAGAGGGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon17 |
miR-516b directly targets SLCO4C1 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-516b | miRNA Mature ID | miR-516b-3p | ||
miRNA Sequence |
UGCUUCCUUUCAGAGGGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon18 |
miR-574 directly targets SLCO4C1 | [ 21 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-574 | miRNA Mature ID | miR-574-5p | ||
miRNA Sequence |
UGAGUGUGUGUGUGUGAGUGUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Left ventricular cardiac tissues of human | ||||
Epigenetic Phenomenon19 |
miR-578 directly targets SLCO4C1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-578 | miRNA Mature ID | miR-578 | ||
miRNA Sequence |
CUUCUUGUGCUCUAGGAUUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon20 |
miR-615 directly targets SLCO4C1 | [ 22 ] | |||
Epigenetic Type |
microRNA | Experiment Method | CLASH | ||
miRNA Stemloop ID |
miR-615 | miRNA Mature ID | miR-615-3p | ||
miRNA Sequence |
UCCGAGCCUGGGUCUCCCUCUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon21 |
miR-670 directly targets SLCO4C1 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-670 | miRNA Mature ID | miR-670-5p | ||
miRNA Sequence |
GUCCCUGAGUGUAUGUGGUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon22 |
miR-6752 directly targets SLCO4C1 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6752 | miRNA Mature ID | miR-6752-3p | ||
miRNA Sequence |
UCCCUGCCCCCAUACUCCCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon23 |
miR-676 directly targets SLCO4C1 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-676 | miRNA Mature ID | miR-676-5p | ||
miRNA Sequence |
UCUUCAACCUCAGGACUUGCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon24 |
miR-6858 directly targets SLCO4C1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6858 | miRNA Mature ID | miR-6858-5p | ||
miRNA Sequence |
GUGAGGAGGGGCUGGCAGGGAC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon25 |
miR-7162 directly targets SLCO4C1 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-7162 | miRNA Mature ID | miR-7162-5p | ||
miRNA Sequence |
UGCUUCCUUUCUCAGCUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.